uniQure
QURE
#4000
Rank
A$4.72 B
Marketcap
A$68.77
Share price
-0.25%
Change (1 day)
224.50%
Change (1 year)

uniQure (QURE) - Cash on Hand

Cash on Hand as of March 2026 : A$0.85 Billion

According to uniQure's latest financial reports the company has A$0.85 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

uniQure - Cash on Hand chart (from 2012 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31A$0.92 B57.3%
2024-12-31A$0.59 B-34.85%
2023-12-31A$0.90 B74.91%
2022-12-31A$0.51 B-32.42%
2021-12-31A$0.76 B140.87%
2020-12-31A$0.31 B-40.97%
2019-12-31A$0.53 B61.83%
2018-12-31A$0.33 B63.34%
2017-12-31A$0.20 B11.06%
2016-12-31A$0.18 B-39.58%
2015-12-31A$0.30 B284.73%
2014-12-31A$79.07 M114.53%
2013-12-31A$36.86 M10912.91%
2012-12-31A$0.33 M-75.93%
2011-12-31A$1.39 M-94.05%
2010-12-31A$23.38 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
A$17.46 B 1,952.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$9.31 B 993.98%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
A$42.97 M-94.95%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
A$0.11 B-86.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$3.22 B 278.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
A$2.46 B 189.30%๐Ÿ‡บ๐Ÿ‡ธ USA